Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health Corp    CVS

Delayed Quote. Delayed  - 07/29 10:03:29 pm
92.72 USD   -0.72%
07/29 CVS HEALTH : Makes Overdose-Reversal Drug Available Without A Prescr..
07/29 CVS HEALTH : to Increase Access to FDA-approved Nasal Naloxone for P..
07/29 AETNA : Earnings schedule for the week of 8/1/2016
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Court Rules Two CVS Florida Pharmacies Can't Ship Pain Pills

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/22/2012 | 11:59pm CEST
   By John Kell 
   Of  
 

A U.S. appeals court said two CVS Caremark Corp. (>> CVS Caremark Corporation) pharmacies in Florida cannot fill prescriptions for certain controlled drugs related to a Drug Enforcement Administration move to halt such sales.

The decision lifted a temporary, administrative stay that was granted to CVS earlier this month, at the time allowing the pharmacies to keep dispensing controlled medications after an appeals court denied the chain's request for preliminary injunction.

The case stems from DEA action that was taken last month against two Sanford, Fla., CVS stores that were alleged to be among four pharmacy customers of drug distributor Cardinal Health Inc. (CAH) that dispensed the pain drug oxycodone based on bad prescriptions.

The U.S. Court of Appeals for the District of Columbia Circuit on Thursday ruled CVS had "not satisfied the stringent requirements for a stay pending appeal." The decision comes roughly a week after an appeals court said a Cardinal Health distribution hub in Florida can't ship prescription painkillers.

In a prepared statement, CVS said it was "disappointed with today's ruling by the court," saying the company had taken actions that have substantially reduced the amount of oxycodone dispensed at the two Florida pharmacies.

"We remain committed to working with the DEA to do everything we can to reduce prescription drug abuse," CVS said.

-By John Kell, Dow Jones Newswires; 212-416-2480; john.kell@dowjones.com

-Jon Kamp and Timothy Martin of The Wall Street Journal contributed to this article

Stocks mentioned in the article : CVS Caremark Corporation
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH CORP
07/29 CVS HEALTH : Makes Overdose-Reversal Drug Available Without A Prescription At Al..
07/29 CVS HEALTH : to Increase Access to FDA-approved Nasal Naloxone for Patients with..
07/29 AETNA : Earnings schedule for the week of 8/1/2016
07/28 CVS HEALTH : Nevada Health Centers receives grant to support Mammovan
07/25 CVS HEALTH : To Hold Second Quarter 2016 Conference Call
07/25 CVS HEALTH : Makes Overdose-Reversal Drug Available Without A Prescription At Al..
07/23 CVS HEALTH : St. Johns Investment Management Company buys $1,105,897 stake in CV..
07/22 CVS HEALTH CORPORATION : To Hold Second Quarter 2016 Conference Call
07/22 CVS HEALTH : Rep. Lipinski Announces Installation of Drop Box for Unwanted Presc..
07/21 CVS HEALTH : Lipinski Announces Installation of Drop Box for Unwanted Prescripti..
More news
Sector news : Drug Retailers - NEC
07/29DJCELESIO : Germany's Celesio Ordered to Sell Pharmacies for Sainsbury Deal Approv..
07/28DJWALGREENS BOOTS ALLIANCE : to Shut Down to Shut Down to Shut Down
07/28DJWALGREENS BOOTS ALLIANCE : to Shut Down Drugstore.com, Focus on Own Website
07/28DJU.S. HOT STOCKS : Hot Stocks to Watch
07/27DJMCKESSON : Profit Declines
More sector news : Drug Retailers - NEC
News from SeekingAlpha
07/28 Walgreens - The Board And The Merger
07/26 Focus On Quality For Long-Term Success
07/22 6 MONTH PORTFOLIO UPDATE : Good News, Double-Digit Increase In Both Income And V..
07/22 CVS HEALTH : Stock Valuations Are Compelling
07/21 CONSUMER STAPLES : Finding Value In An Expensive Sector
Advertisement
Financials ($)
Sales 2016 181 303 M
EBIT 2016 10 754 M
Net income 2016 5 791 M
Debt 2016 25 246 M
Yield 2016 1,76%
P/E ratio 2016 17,07
P/E ratio 2017 14,88
EV / Sales 2016 0,69x
EV / Sales 2017 0,63x
Capitalization 99 583 M
More Financials
Chart CVS HEALTH CORP
Duration : Period :
CVS Health Corp Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Full-screen chart
Technical analysis trends CVS HEALTH CORP
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 112 $
Spread / Average Target 21%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Non-Executive Chairman
David M. Denton Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Stephen J. Gold Chief Information Officer & Executive Vice Preside
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH CORP-5.17%99 583
WALGREENS BOOTS ALLIAN..-6.93%85 774
EXPRESS SCRIPTS HOLDIN..-12.97%47 941
MCKESSON CORPORATION-1.35%43 913
CARDINAL HEALTH INC-6.35%27 238
AMERISOURCEBERGEN CORP..-17.86%18 389
More Results